Background: The Impella device provides percutaneous left ventricular support but may induce aortic regurgitation (AR) due to its transvalvular placement. In this study, we defined Impella-induced AR ...

After demonstrating last year that its miniaturized heart pumps could improve survival shortly after a serious heart attack, Johnson & Johnson MedTech has now shown that the benefits from its Impella ...

The Danish-German Cardiogenic Shock trial found that men implanted with Johnson & Johnson’s Impella CP after experiencing a heart attack with cardiogenic shock gain 600 days of life, on average, ...

SGMC Health has successfully performed its first procedure using the Abiomed Impella 5.5 with SmartAssist, a minimally invasive heart pump that represents a major advancement in the treatment of ...

Introduction: Cardiogenic shock (CS) with severe aortic stenosis (AS) is a drug-resistant hemodynamically unstable condition with high mortality. We report three cases of CS with severe AS that were ...

Use of two high-risk cardiovascular devices—the Watchman (Boston Scientific) left atrial appendage occluder and the Impella (Abiomed) left ventricular assist device—is highest in the United States ...

BOSTON, MA—While the medical community awaits updated guidelines on the use of mechanical circulatory support (MCS) following the DanGer Shock trial, experts here at THT 2025 debated how strong any ...

Antonia Haynes is a Game Rant writer who resides in a small seaside town in England where she has lived her whole life. Beginning her video game writing career in 2014, and having an avid love of ...

The use of left-sided Impella microaxial flow pumps has expanded rapidly for the management of cardiogenic shock, left ventricular unloading and as a bridge to heart transplantation. However, standard ...

The Impella 5.5 with SmartAssist [Image courtesy of Johnson & Johnson MedTech] Johnson & Johnson MedTech today announced the FDA has expanded its approval of Impella heart pumps to treat specific ...

In a groundbreaking achievement, Scarborough Health Network (SHN) has become the first non-cardiac surgical centre in Ontario to successfully use an Impella pump – the world’s tiniest heart pump. The ...

Sales at J&J’s Abiomed business grew 16.3% in the third quarter. The company attributed the increase to growth across all regions and continued adoption of the surgically implanted Impella 5.5 and ...